BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN, or “enGene” or the “Company”), a clinical-stage genetic medicines company whose non-viral lead investigational product ...
Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...
The first successful human bladder transplant could offer hope for people with bladder problems. On May 4, 2025, Oscar Larrainzar, 41, became the first human to successfully receive a bladder ...
News-Medical.Net on MSN
Color vision deficiency is linked to worse survival in bladder cancer
By Dr. Sanchari Sinha Dutta, Ph.D. A large electronic health record study suggests that difficulty recognizing painless blood ...
Detalimogene voraplasmid is a novel, investigational, pivotal-stage, non-viral genetic medicine designed to mitigate systemic risks and deliver durable efficacy for patients with high-risk NMIBC, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results